BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36404041)

  • 21. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
    Silva MT; Araújo A
    J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
    Iribarren JA; Rubio R; Aguirrebengoa K; Arribas JR; Baraia-Etxaburu J; Gutiérrez F; Lopez Bernaldo de Quirós JC; Losa JE; Miró JM; Moreno S; Pérez Molina J; Podzamczer D; Pulido F; Riera M; Rivero A; Sanz Moreno J; Amador C; Antela A; Arazo P; Arrizabalaga J; Bachiller P; Barros C; Berenguer J; Caylá J; Domingo P; Estrada V; Knobel H; Locutura J; López Aldeguer J; Llibre JM; Lozano F; Mallolas J; Malmierca E; Miralles C; Miralles P; Muñoz A; Ocampo A; Olalla J; Pérez I; Pérez Elías MJ; Pérez Arellano JL; Portilla J; Ribera E; Rodríguez F; Santín M; Sanz Sanz J; Téllez MJ; Torralba M; Valencia E; Von Wichmann MA;
    Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):516.e1-516.e18. PubMed ID: 26976381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China.
    Xiao J; Gao G; Li Y; Zhang W; Tian Y; Huang Y; Su W; Han N; Yang D; Zhao H
    PLoS One; 2013; 8(10):e75915. PubMed ID: 24204583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Advanced HIV Disease.
    Summers NA; Armstrong WS
    Infect Dis Clin North Am; 2019 Sep; 33(3):743-767. PubMed ID: 31255383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital.
    Riveiro-Barciela M; Falcó V; Burgos J; Curran A; Van den Eynde E; Navarro J; Villar del Saz S; Ocaña I; Ribera E; Crespo M; Pahissa A
    HIV Med; 2013 Jan; 14(1):21-30. PubMed ID: 22726389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.
    Safdar A; Rubocki RJ; Horvath JA; Narayan KK; Waldron RL
    Clin Infect Dis; 2002 Nov; 35(10):1250-7. PubMed ID: 12410486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune reconstitution inflammatory syndrome versus non-immune reconstitution inflammatory syndrome lymphoma in HIV patients on antiretroviral therapy.
    Choe PG; Park J; Park WB; Kim TM; Song KH; Bang JH; Kim ES; Park SW; Kim HB; Kim NJ; Oh MD; Choe KW
    Int J STD AIDS; 2016 Oct; 27(11):1013-5. PubMed ID: 26826158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain opportunistic infections and tumors in people living with HIV - still a challenge in efficient antiretroviral therapy era.
    Oprea C; Ianache I; Vasile S; Costescu C; Tardei G; Nica M; Umlauf A; Achim C
    J Neurovirol; 2023 Jun; 29(3):297-307. PubMed ID: 37219810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.
    Achenbach CJ; Harrington RD; Dhanireddy S; Crane HM; Casper C; Kitahata MM
    Clin Infect Dis; 2012 Feb; 54(3):424-33. PubMed ID: 22095568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.
    Okome-Nkoumou M; Guiyedi V; Ondounda M; Efire N; Clevenbergh P; Dibo M; Dzeing-Ella A
    Am J Trop Med Hyg; 2014 Feb; 90(2):211-5. PubMed ID: 24323514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient.
    Adachi E; Koibuchi T; Imai K; Kikuchi T; Koga M; Nakamura H; Miura T; Iwamoto A; Fujii T
    Int J STD AIDS; 2012 Aug; 23(8):603-5. PubMed ID: 22930304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV disorders of the brain: pathology and pathogenesis.
    Del Valle L; Piña-Oviedo S
    Front Biosci; 2006 Jan; 11():718-32. PubMed ID: 16146764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.